BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8477206)

  • 1. Host tumor infiltrating lymphocytes in B cell non-Hodgkin's lymphomas.
    Diaz JI; Edinger MG; Stoler M; Tubbs RR
    Leuk Lymphoma; 1993 Jan; 9(1-2):85-90. PubMed ID: 8477206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated T-cell subsets in benign lymphoid hyperplasias and B-cell non-Hodgkin's lymphomas.
    Diaz JI; Edinger MG; Stoler MH; Tubbs RR
    Am J Pathol; 1991 Sep; 139(3):503-9. PubMed ID: 1887860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memory T cell subsets in B cell non-Hodgkin's lymphomas.
    Diaz JI; Muro-Cacho CA; Nicely C; Edinger MG; Tubbs RR
    Leuk Lymphoma; 1996 Jan; 20(3-4):291-5. PubMed ID: 8624469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytolytic (TIA-1+) tumor infiltrating lymphocytes in B cell non-Hodgkin's lymphomas. SWOG Central Repository Members.
    Diaz J; Tubbs R; Stoler M; Grogan T
    Leuk Lymphoma; 1993 Jan; 9(1-2):91-4. PubMed ID: 8477207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD45RA expression by CD4 T lymphocytes in tumors invaded by B-cell non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD).
    Jacob MC; Favre M; Lemarc'Hadour F; Sotto MF; Bonnefoix T; Sotto JJ; Bensa JC
    Am J Hematol; 1992 Jan; 39(1):45-51. PubMed ID: 1531569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-lymphocyte subpopulations in B-cell-derived non-Hodgkin's lymphomas and Hodgkin's disease.
    Knowles DM; Halper JP; Jakobiec FA
    Cancer; 1984 Aug; 54(4):644-51. PubMed ID: 6234982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD3 hyporesponsiveness and in vitro apoptosis are features of T cells from both malignant and nonmalignant secondary lymphoid organs.
    Agrawal S; Marquet J; Delfau-Larue MH; Copie-Bergman C; Jouault H; Reyes F; Bensussan A; Farcet JP
    J Clin Invest; 1998 Nov; 102(9):1715-23. PubMed ID: 9802885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cd4+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome.
    Ansell SM; Stenson M; Habermann TM; Jelinek DF; Witzig TE
    J Clin Oncol; 2001 Feb; 19(3):720-6. PubMed ID: 11157023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of antitumor-specific cytotoxic T lymphocytes from autologous tumor infiltrating lymphocytes in non-Hodgkin's lymphomas.
    Chaperot L; Delfau-Larue MH; Jacob MC; Molens JP; Roussel B; Agrawal S; Farcet JP; Gressin R; Sotto JJ; Bensa JC; Plumas J
    Exp Hematol; 1999 Jul; 27(7):1185-93. PubMed ID: 10390194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present.
    Wang Q; Stanley J; Kudoh S; Myles J; Kolenko V; Yi T; Tubbs R; Bukowski R; Finke J
    J Immunol; 1995 Aug; 155(3):1382-92. PubMed ID: 7636203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer.
    Wagner P; Koch M; Nummer D; Palm S; Galindo L; Autenrieth D; Rahbari N; Schmitz-Winnenthal FH; Schirrmacher V; Büchler MW; Beckhove P; Weitz J
    Ann Surg Oncol; 2008 Aug; 15(8):2310-7. PubMed ID: 18521684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer.
    Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman JJ; Smith CV; Pecorelli S; Radominska-Pandya A; Cannon MJ; Parham GP
    Gynecol Obstet Invest; 2001; 51(4):254-61. PubMed ID: 11408737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of T cell subsets in peripheral blood of B cell non-Hodgkin's lymphoma patients.
    Dehghani M; Sharifpour S; Amirghofran Z; Zare HR
    Med Oncol; 2012 Dec; 29(4):2364-71. PubMed ID: 22307765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of flow cytometric immunophenotyping and bone marrow trephine biopsy in the detection of lymphoid bone marrow infiltration in non-Hodgkin's lymphomas.
    Mazur G; Hałoń A; Wróbel T; Jeleń M; Kuliczkowski K
    Neoplasma; 2004; 51(3):159-63. PubMed ID: 15254666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma.
    Laane E; Tani E; Björklund E; Elmberger G; Everaus H; Skoog L; Porwit-MacDonald A
    Cytometry B Clin Cytom; 2005 Mar; 64(1):34-42. PubMed ID: 15669024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low grade malignant non-Hodgkin's lymphomas and peripheral pleomorphic T-cell lymphomas in childhood--a BFM study group report.
    Bucsky P; Feller AC; Reiter A; Beck J; Bertram U; Eschenbach C; Gerein V; Lakomek M; Stollmann B; Tausch W
    Klin Padiatr; 1990; 202(4):258-61. PubMed ID: 2203939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell subsets in peripheral blood of patients with newly diagnosed and posttreatment Hodgkin's and non-Hodgkin's lymphomas. Analysis by monoclonal antibody staining and flow cytometry.
    De Angelis P; Kimmel M; Lacher M; Filippa D; Melamed MR
    Anal Quant Cytol Histol; 1988 Aug; 10(4):235-42. PubMed ID: 2971365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma.
    Stopeck AT; Gessner A; Miller TP; Hersh EM; Johnson CS; Cui H; Frutiger Y; Grogan TM
    Clin Cancer Res; 2000 Oct; 6(10):3904-9. PubMed ID: 11051236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: relationship to HLA expression and host immunocompetence.
    List AF; Spier CM; Miller TP; Grogan TM
    Leukemia; 1993 Mar; 7(3):398-403. PubMed ID: 7680400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responses to T cell receptor/CD3 and interleukin-2 receptor stimulation are altered in T cells from B cell non-Hodgkin's lymphomas.
    Kudoh S; Wang Q; Hidalgo OF; Rayman P; Tubbs RR; Edinger MG; Kolenko V; Panuto J; Bukowski R; Finke JH
    Cancer Immunol Immunother; 1995 Sep; 41(3):175-84. PubMed ID: 7553687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.